From: Oncolytic viruses for triple negative breast cancer and beyond
Virus | Receptor | Vector | Modification | Mechanism | Ref |
---|---|---|---|---|---|
Adenovirus | Coxsackie and adenovirus receptor (CAR), CD46, Desmoglein-2(DSG-2) | CNHK600-IL24 | Arm with IL-24 | Induce TNBC apoptosis | [41] |
p55-hTERT-HRE-TRAIL | Arm with P55-HTERT-HRE-TRAIL | Target TNBC and induce apoptosis | [42] | ||
OBP-401 adenovirus | Arm with the human telomerase reverse transcriptase (hTERT) gene | Increase the targeting to cancer cells | [43] | ||
Ad5-10miR145T | Carry ten miR-145-5p target sequences | Target miR-145-5P | [44] | ||
Ad.DCN | Express decorin protein | Promote the expression of decorin | [45] | ||
SG400-E2F/IL-15 | Replace the endogenous promoter with the E2F-1 promoter and arm with IL-15 gene | Target E2F and promote the expression of IL-15 | [46] | ||
Herpes simplex virus | Herpes virus entry mediator (HVEM), nectin1/2, heparan sulfate proteoglycans (HSPG) | G47Δ | Delete α47 and γ34.5 genes; Insert Escherichia Coli LacZ into ICP6 | Enhance cytotoxicity to tumor cells | |
GD116 | Insert MyD116 C-terminus | Enhance the replication and virulence | [49] | ||
G47Δ-mIL12 | Insert IL-12 into G47Δ | Enhance antitumor immune response | [50] | ||
Vaccinia virus | Glycosaminoglycans/ laminin, macrophage receptor with collagenous structure (MARCO) | VV40L | Arm with CD40 ligand | Target CD40 | [51] |
VG9-IL-24 | Arm with IL-25 | Induce apoptosis | [52] | ||
Reovirus | Carbohydrates, Junction adhesion molecule-A(JAM-A) | reo-dox | Conjugate Doxorubicin | Enhance cytotoxicity | [53] |
Vesicular Stomatitis Virus | Low-density lipoprotein (LDLR) | VSVd51 | A mutation in the matrix protein | Expands the tropism for diverse cancer types | [54] |
Measles virus | CD46, nectin-4 | rMV-SLAMblind | Mutate R533A in the H protein | Entry cancer cells through nectin-4 receptor | [55] |
rMV-BNiP3 | Arm with BNiP3 | Enhance the ability of Inducing apoptosis | [56] | ||
Newcastle disease virus | Sialic acid (SA) | rAF-IL12 | Insert IL-12 | Enhance anti-tumor immune response | [57] |
Maraba virus | Low-density lipoprotein receptor (LDLR) | MG1 | Mutate G protein (Q242R) and M protein (L123W) | Improve virulence and reduce the ability to kill normal cells | |
Coxsackievirus | Coxsackie and adenovirus receptor(CAR), Intracellular adhesion molecule-1(ICAM-1) | CVA21 | Natural strain | Capable of lytic infection of breast cancer cells | [60] |